首页> 中文期刊>中国当代医药 >舒血宁辅助治疗对呼吸心跳骤停患者院前心肺复苏成功率影响的临床研究

舒血宁辅助治疗对呼吸心跳骤停患者院前心肺复苏成功率影响的临床研究

     

摘要

目的:探讨舒血宁辅助治疗对呼吸心跳骤停患者院前心肺复苏成功率的影响。方法选择本院2011年1月~2013年10月收治的院外呼吸心跳骤停患者100例进行研究并分为两组。对照组患者在常规抢救药物治疗的基础上进行常规心肺复苏,观察组在对照组基础上联合舒血宁静脉注射治疗。比较两组的心肺复苏成功率。结果观察组的心肺复苏成功率为67.31%,显著高于对照组的37.50%(P<0.01)。结论舒血宁辅助治疗应用于呼吸心跳骤停患者院前心肺复苏中,能够有效提高其复苏成功率,降低死亡率,值得临床推广应用。%Objective To explore the the influence of Shuxuening auxiliarily treating on prehospital cardiopulmonary resuscitation success rate for patients with respiratory and cardiac arrest. Methods 100 patients with respiratory and cardiac arrest in our hospital from January 2011 to October 2013 were selected and they were divided into the two groups.The control group were treated with the conventional cardiopulmonary resuscitation on the basis of conventional salvage drug therapy,while the observation group were treated with Shuxuening intravenous therapy on the basis of the control group.The cardiopulmonary resuscitation success rate of the two groups was compared. Results The cardiopul-monary resuscitation success rate in the observation group (67.31%) was significantly higher than that in the control group (37.50%) (P<0.01). Conclusion Shuxuening adjuvant therapy using for the respiratory and cardiac arrest can effectively improve the success rate of recovery and reduce the mortality,and it is worthy of clinical promotion and application.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号